FDA·Medicines·August 19, 2026

Heritage Pharmaceuticals recalls clindamycin oral solution over particles and white flakes in the liquid

Bottles of clindamycin palmitate hydrochloride for oral solution (75 mg/5 mL, 100 mL) were found to have particles and white flakes in the liquid after it was mixed.

What to do

The notice does not give instructions. Read the official notice for details.

Note from Recalled Today: Don't stop taking a prescribed medicine before you talk to your pharmacist or doctor.

Recall details

Product
CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION, USP, 75 mg/5 mL, Rx Only, 100 mL, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-603-51
Hazard
Presence of Foreign Substance: presence of particles and white flakes in the reconstituted bottles.
Where sold
Nationwide within the U.S
FDA classification
Class II · Ongoing
Classified by FDA
August 14, 2026
Recall started
July 30, 2026
FDA enforcement report
August 19, 2026
Identifiers
  • Codes: Lot #: 2411550, Exp. 2026/NOV.
  • FDA recall number: D-0768-2026

The headline, summary and steps above are written in plain English from the official notice below. Identifiers are copied exactly as the agency published them. Always check the official notice before you act.

Official notice

The notice's own wording from FDA.

Product
CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION, USP, 75 mg/5 mL, Rx Only, 100 mL, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-603-51
Reason for recall
Presence of Foreign Substance: presence of particles and white flakes in the reconstituted bottles.
Classification
Class II (Ongoing)
Distribution
Nationwide within the U.S

Related recalls